Evidence map›Paper›PMID 42707229›Full record

ReviewFrontiers in pharmacology2026

Antifibrotic mechanism of curcumin and its therapeutic potential in multi-organ diseases.

Ting Luo, Jia Gao, Qingzhi Liang, Yi Su, Xiaoqin Liu, Shu Ou, Yaowen Zhang, Hong Gao, Yi Fu, Chunguang Xie

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ting Luo *Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
Jia Gao *Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
Qingzhi Liang *Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
Yi SuHospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
Xiaoqin LiuHospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
Shu OuHospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
Yaowen ZhangHospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
Hong GaoHospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
Yi FuThe Third Affiliated Hospital of Yunnan University of Chinese Medicine, Kunming, Yunnan, China.
Chunguang XieHospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fibrosis is the outcome of chronic diseases and manifests as an abnormal repair process in which normal parenchyma is progressively replaced by deposited extracellular matrix. It leads to organ dysfunction and is associated with high morbidity, disability, and mortality, thereby becoming a major public health concern. Traditional Chinese medicine shows multi-target, multi-pathway strategies with favorable safety profiles. Curcumin (CUR), a polyphenolic metabolite derived from

Indexed as

curcuminfibrosisnatural productspharmacological mechanismtreatment

Identifiers

PMID42707229
PMCPMC13547310

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.